Management raised full year revenue guidance from a minimum of $375 million to a range of $390 million to $410 million. Pro forma fully synergized adjusted EBITDA for 2025 is now guided to $220 ...
CorMedix again raises its full-year 2025 pro forma net revenue guidance to a range of $390 to $410 million, and fourth quarter net revenue guidance to a range of $115 to $135 million. In addition, the ...
CorMedix again raises its full-year 2025 pro forma net revenue guidance to a range of $390 to $410 million, and fourth quarter net revenue guidance to a range of $115 to $135 million. In addition, the ...
Two decades ago, property investing relied on gut instinct and local gossip. The right address, a handshake, and a rough sense of what the neighbour’s house sold for were often enough to close a deal.
Women at Pitt are carving out their own space in finance, from the classroom to conversations about financial independence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback